Sign in
CompletedNo phase

Xpert Hepatitis-C Virus (HCV) Test on the GeneXpert Xpress System

Key facts

Who runs it
Cepheid
Where
Lexington, United StatesSee the site
Trial code
Status
Completed
People taking part
1,012 people enrolled
Started
6 Feb 2024
Ended
6 Jun 2024
Type of study
Observational
Treatments tested
  • Xpert HCV
Record updated
19 July 2024

Who can take part

Age
18 years and older
Sex
Women and men

The registry criteria, word for word

Show all 4 criteriaShow less

Who can take part

  • Participant was ≥18 years old
  • Participant was not on treatment at time of enrollment based on review of medical records or self-reported
  • Participant had signs and symptoms and/or is considered at-risk of HCV infection

Who cannot take part

  • Clinician assessed that the participant was not suitable for inclusion

Where in United States

  • University of KentuckyLexington, United States

About the trial

What the trial wants to find out

A multi-site prospective, all comers study that was conducted at geographically diverse locations in the United States.

The group in the trial

  • Capillary whole blood

    Capillary whole blood from individuals with signs and symptoms and/or at-risk of HCV infection

    Treatment: Xpert HCV

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Clinical Evaluation of the Xpert® HCV Test on the GeneXpert® Xpress System
Publications
Record updated
19 July 2024